Abstract:In the setting of central precocious puberty (CPP), the motivation for hormonal intervention is to help the child to reach a taller adult stature than she would achieve otherwise. While gonadotropin-releasing hormone analogs (GnRHa) constitute an established treatment for improving adult stature in girls presenting with CPP up to age 6 (true precocious puberty), it is not yet clear whether or not the same is true in the setting of CPP presented in girls beyond age 6 (advance puberty). GnRHa may slow growth velocity, offsetting the anticipated improvement in final height that should have resulted from the increased time before growth plate fusion. Consequently, it's been suggested that growth hormone (GH) should be combined with GnRHa to improve the results.Few controlled prospective studies have been performed with GnRHa in children and many conclusions rely in part on collective expert opinion. Therefore, the literature was searched and relevant studies were selected using the search terms "gonadotropin releasing hormone agonist," "precocious puberty/early puberty," and "GnRH analogue." After selected articles were screened for relevance, the process yielded 8 studies, the results of which were then pooled in a meta-analysis aimed at evaluating the effects of GnRHa therapy both with and without added GH in the setting of early puberty. A significant difference was elucidated in final height and predicted adult height comparing GnRHa and combined GnRHa/GH groups. However, no significant difference was elucidated in final height standard deviation scores (SDS) and initial height SDS when comparing GnRHa and control groups. At the same time, the final analysis revealed no significant difference in final height SDS and initial height SDS when GnRHa and combined GnRHa/GH groups were compared.The results suggest GnRHa therapy may have a positive effect on final adult height in girls with early puberty, while adding GH to the treatment may suggest more advantage. Interpretation of the results requires extreme caution, given the complexity of the outcome analysis. Final height gain may prove to be a more appropriate measure of treatment efficacy in any case.

Gene Expression Related to Growth Axis and Gonadal Axis in Puberty Rats

[Long-Acting Gonadotropin-Releasing Hormone Analogue in Treatment of Idiopathic Central Precocious Puberty in Girls].

Influence and Mechanism of Gonadotropin- Releasing Hormone Analog on Growth in Rats

Effects of gonadotropin releasing hormone analog and growth hormone on height in girls with idiopathic central precocious puberty]

[Impact of Gonadotropin-Releasing Hormone Analogs on Body Mass Index in Girls with Idiopathic Central Precocious Puberty: a Long-Term Follow-Up Study].

Application of gonadotropin-releasing hormone analogues in children with central precocious puberty

The Regulatory Effect of Insulin-Like Growth Factor-2 on Hypothalamic Gonadotropin-Releasing Hormone Neurons During the Pubertal Period

Effects Of"compound Rehmannia Decoction"Combined with Recombinant Human Growth Hormone on Sex Development of Pubertal Female Rats

Intracerebroventricular injection of RFRP-3 delays puberty onset and stimulates growth hormone secretion in female rats

Long-Term Outcomes of Treatments for Central Precocious Puberty or Early and Fast Puberty in Chinese Girls

Gonadotropin Releasing Hormone Agonist Treatment to Increase Final Stature in Children with Precocious Puberty: a Meta-Analysis.

Growth Hormone Receptor Gene Expression in Puberty

Is Precocious Puberty Linked to Hypothalamic Expression of Arginine-Phenylalanine-amide-related Peptide?

Effects of "Compound Rehmannia Decoction" on the expressions of KiSS-1,GPR54 and Ghrelin mRNA in hypothalamuses of female puberty rats

The expression of IGFBP-5 in the reproductive axis and effect on the onset of puberty in female rats

Growth, Growth Hormone and Sex Steroid Secretion in Girls with Central Precocious Puberty Treated with a Gonadotrophin Releasing Hormone (GnRH) Analogue

The Effects of Gonadotropin-Releasing Hormone Analog and a Combination of Gonadotropin-Releasing Hormone Analog and Recombinant Human Growth Hormone on Adult Height in Girls with Early Puberty

Efficacy of Treatment with Gonadotropin-Releasing Hormone Analogue Alone or Combined with Recombinant Human Growth Hormone in Pubertal Short Children

Benefits from the first year of GnRHa therapy in boys with idiopathic central precocious puberty when initiating treatment after age 9 years: findings from a real-world retrospective study

Effect of Ziyin Xiehuo Formulae on Long Bone Growth and Related Genes in Pubertal Rats

The Epigenetic Role of HTR1A Antagonist in Facilitating GnRH Expression for Pubertal Initiation Control